Testing of peptidomimetic compounds CDR 2001 and CDR 2010 against human breast cancer cell lines and xenografts with HER-2/neu overexpression /
by Treise Tomlinson Chestnut.
Description
Viewability
Item Link | Original Source |
---|---|
Limited (search only) | University of California |